MedPath

SUPPORT-D Intervention for Persons With Alzheimer's Disease and Their Caregivers

Not Applicable
Completed
Conditions
Mild Cognitive Impairment
Alzheimer Disease
Interventions
Behavioral: A Program of SUPPORT-D (dementia)
Registration Number
NCT05501119
Lead Sponsor
Medical University of South Carolina
Brief Summary

The purpose of this research is pilot test a nurse led intervention previously used in patients with pulmonary fibrosis and their caregivers in a new population (persons living with Mild Cognitive Impairment or Alzheimer's disease and their caregivers. The researchers hypothesize improving advanced care planning in this population will result in enhanced quality of life over illness trajectory and improve safety for community dwelling PWD/CG dyads. Findings from this study will inform additional necessary adaptations required prior to conducting larger scale powered randomized control trial.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
58
Inclusion Criteria

The participants in this study include persons with Alzheimer's disease (PWD) and their caregivers (CG.

  • Persons with Alzheimer's Disease (investigators anticipate cognitive impairment within this group)
  • 18 years old or older
  • Diagnosis of Alzheimer's Disease or suspected Alzheimer's disease (FAST score < 4)
  • Able to read and speak English (intervention in English)

Caregivers (CG)

  • > 18 years old
  • Non-paid (eliminates professional caregivers)
  • Provides care to someone living with Alzheimer's Disease or suspected Alzheimer's disease (self-report)
  • Able to read and speak English (written materials in English)
  • No diagnosis of cognitive impairment
Exclusion Criteria
  • Inability or unwillingness to provide informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
SUPPORT-D GroupA Program of SUPPORT-D (dementia)-
Primary Outcome Measures
NameTimeMethod
Change in Alzheimer's Disease Knowledge Scale (ADKS) Scorebaseline, at study completion, an average of 8 weeks

30 items (T/F) summed total of correct items higher score indicates higher knowledge (scores range from 0-30)

Acceptability of Intervention Measure (AIM) Scoreat study completion, an average of 8 weeks

4 items (5 point Likert scale) average score across items higher score indicates more acceptability of intervention (raw score ranges from 4-20)

Feasibility Scoreat study completion, an average of 8 weeks

4 items (5 point Likert scale) average score across items higher score indicates greater feasibility of intervention (raw scores range from 4-20)

Change Zarit Caregiver Burden Scorebaseline, at study completion, an average of 8 weeks

12 items (5 point Likert scale (0-4)) summed score with higher scores indicating greater caregiver distress (raw scores range from 0-48)

Change in Perceived Stress Scale Scorebaseline and at study completion, an average of 8 weeks

10 items (4 point Likert scale ranging from 0-4) summed score across items with higher scores indicate greater levels of stress (scores range from 0-40)

Change in Quality of Life-Alzheimer's Disease (QoL-AD) Scorebaseline and at study completion, an average of 8 weeks

13 items (4 point Likert scale ranging from 1-4) summed score across items with higher scores indicating better quality of life (scores range from 13-52)

Change in Self-efficacy for Caregiving Scorebaseline and at study completion, an average of 8 weeks

8 items rated from 1-10 mean score across items with higher scores indicating higher self-efficacy (raw scores range from 8-80)

Change in Safety Assessment Scale Scorebaseline and at study completion, an average of 8 weeks

16 items with response options ranging from 0 to 4. The minimum score is 0, indicating no safety concerns, while the maximum score is 64, indicating significant safety risks.

Appropriateness of Intervention Scoreat study completion, an average of 8 weeks

4 items (5 point Likert scale) average score across items higher score indicates greater appropriateness of intervention (scores range from 4-20)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Medical University of South Carolina

🇺🇸

Charleston, South Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath